EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...

Now, the company will aim to show the drug helps patients with eczema and asthma in larger, placebo-controlled trial.

Allied Market Research published a report, titled, "Dyspnea treatment Market - Global Opportunity Analysis and Industry ...

India’s air quality challenge is no longer a seasonal concern. It is a persistent public health issue that touches families, cities and insurers alike. As claims linked to respiratory and cardiac ...

According to research by SNS Insider, the U.S. Electronic Drug Delivery Devices Market is projected to reach USD 36.85 billion by 2032, driven by rising chronic disease prevalence and the growing ...

Real estate company Wexford partnered with Atrium Health to build The Pearl, a $1.5 billion innovative district and home for ...

CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation announced today that data from two of its ...

Menopause has a wide range of symptoms and brings several health risks. Yet people worldwide know little about it and awareness and care services remain inadequate, experts warn.

The study also reported that interventions using a multifocal approach with evidence-based strategies to address clinical, ...

Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025WATERTOWN, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) ...

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted ...